SCHEMBL1425858

SCHEMBL1425858

O=S(=O)(O)OCC(O)COS(=O)(=O)O

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.35
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276968 0.87 LMNA (0.38) CA2
SCHEMBL10585264 0.87 LMNA (0.38) CA2
SCHEMBL9742566 0.85 CA1 (0.35) CA2
SCHEMBL29077038 0.85 LMNA (0.36)
SCHEMBL2383311 0.85 TSHR (0.32) CA2POLBTSHRTDP1
SCHEMBL8332025 0.85 GABRR1 (0.36) CA2POLBTSHR
SCHEMBL4107502 0.85 LMNA (0.36)
SCHEMBL1726353 0.85 LMNA (0.36)
Phosphine SCHEMBL15612730 0.85 LMNA (0.36)
Water SCHEMBL8206792 0.85 LMNA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010115869-A1 PROPOFOL PHOSPHONYL DERIVATIVES, SYNTHESIS, AND USE IN LONG ACTING FORMULATIONS SEPS PHARMA N.V. (BE) 2010-10-14 WO claimed
EP-1045827-B1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AG (DE) 2003-09-10 EP claimed
US-6437181-B1 Method for producing (S,S)-N,N′-ethylenediaminedisuccinic acid, analogous compounds or salts thereof BASF AKTIENGESELLSCHAFT (DE) 2002-08-20 US claimed
JP-2002500212-A 2002-01-08 JP claimed
EP-1045827-A1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AKTIENGESELLSCHAFT (DE) 2000-10-25 EP claimed
WO-1999035121-A1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AKTIENGESELLSCHAFT (DE) 1999-07-15 WO claimed
EP-2301902-B1 HIGH-EARLY-STRENGTH AGENT FOR HYDRAULIC COMPOSITION KAO CORP (JP) 2015-02-25 EP disclosed
EP-2301901-B1 METHOD FOR PRODUCING HYDRAULIC POWDER KAO CORP (JP) 2014-03-26 EP disclosed
US-8598255-B2 Early strengthening agent for hydraulic composition KAO CORPORATION (JP) 2013-12-03 US disclosed
US-8567703-B2 Method for producing hydraulic powder KAO CORPORATION (JP) 2013-10-29 US disclosed
US-20110100266-A1 EARLY STRENGTHENING AGENT FOR HYDRAULIC COMPOSITION KAO CORPORATION (JP) 2011-05-05 US disclosed
US-20110100264-A1 METHOD FOR PRODUCING HYDRAULIC POWDER KAO CORPORATION (JP) 2011-05-05 US disclosed
EP-2301902-A1 HIGH-EARLY-STRENGTH AGENT FOR HYDRAULIC COMPOSITION Kao Corporation (JP) 2011-03-30 EP disclosed
EP-1045827-B1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AG (DE) 2003-09-10 EP disclosed
US-6437181-B1 Method for producing (S,S)-N,N′-ethylenediaminedisuccinic acid, analogous compounds or salts thereof BASF AKTIENGESELLSCHAFT (DE) 2002-08-20 US disclosed
US-6437181-B1 Method for producing (S,S)-N,N′-ethylenediaminedisuccinic acid, analogous compounds or salts thereof BASF AKTIENGESELLSCHAFT (DE) 2002-08-20 US disclosed
EP-1045827-A1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AKTIENGESELLSCHAFT (DE) 2000-10-25 EP disclosed
EP-1045827-A1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AKTIENGESELLSCHAFT (DE) 2000-10-25 EP disclosed
WO-1999035121-A1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AKTIENGESELLSCHAFT (DE) 1999-07-15 WO disclosed
WO-1999035121-A1 METHOD FOR PRODUCING (S,S)-N,N'-ETHYLENEDIAMINE DISUCCINIC ACID, ANALOGOUS COMPOUNDS OR SALTS THEREOF BASF AKTIENGESELLSCHAFT (DE) 1999-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110100266-A1 EARLY STRENGTHENING AGENT FOR HYDRAULIC COMPOSITION SMARCA2, TMEM63A, SMARCA1 CA2 1290/4885POLB 383/4885TSHR 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.